1. Recent Efforts in the Discovery of Urease Inhibitor Identifications
- Author
-
Wan-Qin Song, Su-Ya Li, Zhu-Ping Xiao, and Mei-Ling Liu
- Subjects
biology ,Urease ,Chemistry ,Acetohydroxamic acid ,Struvite nephrolithiasis ,General Medicine ,Helicobacter pylori ,biology.organism_classification ,medicine.disease_cause ,Proteus mirabilis ,Anti-Bacterial Agents ,chemistry.chemical_compound ,Biochemistry ,Drug Discovery ,biology.protein ,medicine ,Urea ,Potency ,Enzyme Inhibitors ,Ureaplasma urealyticum ,medicine.drug - Abstract
Abstract: Urease is an attractive drug target for designing anti-infective agents against pathogens such as Helicobacter pylori, Proteus mirabilis, and Ureaplasma urealyticum. In the past century, hundreds of medicinal chemists focused their efforts on explorations of urease inhibitors. Despite the FDA’s approval of acetohydroxamic acid as a urease inhibitor for the treatment of struvite nephro-lithiasis and the widespread use of N-(n-butyl)thiophosphoric triamide as a soil urease inhibitor as nitrogen fertilizer synergists in agriculture, urease inhibitors with high potency and safety are urgently needed. Exploration of novel urease inhibitors has therefore become a hot research topic recently. Herein, inhibitors identified worldwide from 2016 to 2021 have been reviewed. They structurally belong to more than 20 classes of compounds such as urea/thioure analogues, hydroxamic acids, sul-fonamides, metal complexes, and triazoles. Some inhibitors showed excellent potency with IC50 val-ues lower than 10 nM, having 10000-fold higher potency than the positive control thiourea.
- Published
- 2021